GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Shares Outstanding (EOP)

Vilacto Bio (Vilacto Bio) Shares Outstanding (EOP) : 1,914.43 Mil (As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Vilacto Bio's shares outstanding for the quarter that ended in Jun. 2019 was 1,914.43 Mil.

Vilacto Bio's quarterly shares outstanding increased from Mar. 2019 (597.07 Mil) to Jun. 2019 (1,914.43 Mil). It means Vilacto Bio issued new shares from Mar. 2019 to Jun. 2019 .

Vilacto Bio's annual shares outstanding increased from Mar. 2018 (90.00 Mil) to Mar. 2019 (597.07 Mil). It means Vilacto Bio issued new shares from Mar. 2018 to Mar. 2019 .


Vilacto Bio Shares Outstanding (EOP) Historical Data

The historical data trend for Vilacto Bio's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Shares Outstanding (EOP) Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Shares Outstanding (EOP)
Get a 7-Day Free Trial 90.00 90.00 90.00 90.00 597.07

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.00 90.00 110.44 597.07 1,914.43

Competitive Comparison of Vilacto Bio's Shares Outstanding (EOP)

For the Biotechnology subindustry, Vilacto Bio's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilacto Bio's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vilacto Bio's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Vilacto Bio's Shares Outstanding (EOP) falls into.



Vilacto Bio Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Vilacto Bio  (GREY:VIBI) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Vilacto Bio Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilacto Bio (Vilacto Bio) Business Description

Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.